Abstract
Integral membrane proteins mediate a myriad of cellular processes and are the target of many therapeutic drugs. Enhancement and extension of the functional scope of membrane proteins can be realized by membrane incorporation of engineered nanoparticles designed for specific diagnostic and therapeutic applications. In contrast to hydrophobic insertion of small amphiphilic molecules, delivery and membrane incorporation of particles on the nanometric scale poses a crucial barrier for technological development. In this perspective, the transformative potential of biomimetic membrane proteins (BMPs), current state of the art, and the barriers that need to be overcome in order to advance the field are discussed.
Original language | English |
---|---|
Article number | 1903006 |
Journal | Small |
Volume | 15 |
Issue number | 52 |
DOIs | |
State | Published - 1 Dec 2019 |
Bibliographical note
Publisher Copyright:© 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Funding
The authors thank Drs. Jack Li, Yung Kuo, Eugene Stulz, and Volodymyr Shvadchak for extremely helpful discussions. This work has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement No. 669941, by the Human Frontier Science Program (HFSP) research grant RGP0061/2015, by the BER program of the Department of Energy Office of Science grant DE-FC03-02ER63421, and by the STROBE National Science Foundation Science & Technology Center, Grant No. DMR-1548924.
Funders | Funder number |
---|---|
Department of Energy Office of Science | DE-FC03-02ER63421 |
European Union's Horizon 2020 research and innovation program | |
STROBE National Science Foundation Science & Technology Center | DMR-1548924 |
Human Frontier Science Program | RGP0061/2015 |
Horizon 2020 Framework Programme | 669941 |
European Commission |
Keywords
- biomimetic membrane proteins
- membrane proteins
- nanoparticles insertion into membranes
- nanorods
- quantum dots